Erowid.org: Erowid Reference 6590 : A Human Pilot Study - Safety and Efficacy of 3,4-Methylenedioxymethamphetamine (MDMA) Assisted Psychotherapy in the Treatment of Chronic PTSD : Mithoefer MC, Brady K.

Erowid References Database

Mithoefer MC, Brady K.. “A Human Pilot Study - Safety and Efficacy of 3,4-Methylenedioxymethamphetamine (MDMA) Assisted Psychotherapy in the Treatment of Chronic PTSD”. . 2001 January 31. <a name="ref">Mithoefer MC, Brady K..</a> <a href="/references/6590">"A Human Pilot Study - Safety and Efficacy of 3,4-Methylenedioxymethamphetamine (MDMA) Assisted Psychotherapy in the Treatment of Chronic PTSD"</a> <i></i>. 2001 January 31.
Text Abstract (this page) Full Text - English (private) Show Articles by Mithoefer MC Brady K. Article IDs Erowid RefID: 6590 PubMedID: unknown Collections Hofmann Collection MDMA Collection All References	Abstract This protocol is for a pilot study into the use of 3,4- methylenedioxymethamphetamine(MDMA) to treat patients with chronic Post Traumatic Stress Disorder (PTSD). This study builds on research begun in the Phase 1 dose/response trial conducted at Harbor-UCLA Medical Center by Dr.Charles Grob. (Grob 1995) This pilot study will gather preliminary information about the safety and efficacy of MDMA-assisted psychotherapy in stimulating therapeutic processing of traumatic experiences, with the goal of reducing or relieving symptoms of PTSD.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]